<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0007">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Cheng</surname>
    <given-names>A. C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Coleman</surname>
    <given-names>R. G.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Smyth</surname>
    <given-names>K. T.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cao</surname>
    <given-names>Q.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Soulard</surname>
    <given-names>P.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Caffrey</surname>
    <given-names>D. R.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Salzberg</surname>
    <given-names>A. C.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Huang</surname>
    <given-names>E. S.</given-names>
   </name>
  </person-group> (
  <year>2007</year>). 
  <article-title>Structure-based maximal affinity model predicts small-molecule druggability</article-title>. 
  <source>
   <italic toggle="yes">Nature Biotechnology</italic>
  </source>, (
  <issue>1</issue>), 
  <fpage>71</fpage>â€“
  <lpage>75</lpage>. 
  <pub-id pub-id-type="doi">10.1038/nbt1273</pub-id>
 </mixed-citation>
</ref>
